Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A D Kay

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Archives of Neurology|October 1, 1986
Cerebrospinal fluid biopterin is decreased in Alzheimer's diseaseA D Kay, S Milstien, S Kaufman, et al.
Frontiers in Physiology|September 26, 2022
Effects of isometric resistance training and detraining on ambulatory blood pressure and morning blood pressure surge in young normotensivesA W Baross, A D Kay, B A Baxter, et al.
Annals of Neurology|April 1, 1987
Cerebrospinal fluid monoaminergic metabolites are elevated in adults with Down's syndromeA D Kay, M B Schapiro, A K Riker, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|June 21, 2014
Range of motion, neuromechanical, and architectural adaptations to plantar flexor stretch training in humansA J Blazevich, D Cannavan, C M Waugh, et al.
Archives of Neurology|March 1, 1988
Cerebrospinal fluid somatostatin and neuropeptide Y. Concentrations in aging and in dementia of the Alzheimer type with and without extrapyramidal signsJ R Atack, M F Beal, C May, et al.
Journal of Mental Deficiency Research|September 1, 1987
Cerebrospinal fluid monoamines in Down's syndrome adults at different agesM B Schapiro, A D Kay, C May, et al.
Annals of Neurology|September 1, 1985
Clinical history, brain metabolism, and neuropsychological function in Alzheimer's diseaseN R Cutler, J V Haxby, R Duara, et al.
Neurobiology of Aging|January 1, 1987
CSF and serum concentrations of albumin and IgG in Alzheimer's diseaseA D Kay, C May, N M Papadopoulos, et al.
Science (New York, N.Y.)|August 19, 1983
Down's syndrome in adults: brain metabolismM Schwartz, R Duara, J Haxby, et al.
Neurology|April 1, 1988
Cerebrospinal fluid monoamine markers are decreased in dementia of the Alzheimer type with extrapyramidal featuresJ A Kaye, C May, E Daly, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Archives of Neurology|October 1, 1986
Cerebrospinal fluid biopterin is decreased in Alzheimer's diseaseA D Kay, S Milstien, S Kaufman, et al.
Frontiers in Physiology|September 26, 2022
Effects of isometric resistance training and detraining on ambulatory blood pressure and morning blood pressure surge in young normotensivesA W Baross, A D Kay, B A Baxter, et al.
Annals of Neurology|April 1, 1987
Cerebrospinal fluid monoaminergic metabolites are elevated in adults with Down's syndromeA D Kay, M B Schapiro, A K Riker, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|June 21, 2014
Range of motion, neuromechanical, and architectural adaptations to plantar flexor stretch training in humansA J Blazevich, D Cannavan, C M Waugh, et al.
Archives of Neurology|March 1, 1988
Cerebrospinal fluid somatostatin and neuropeptide Y. Concentrations in aging and in dementia of the Alzheimer type with and without extrapyramidal signsJ R Atack, M F Beal, C May, et al.
Journal of Mental Deficiency Research|September 1, 1987
Cerebrospinal fluid monoamines in Down's syndrome adults at different agesM B Schapiro, A D Kay, C May, et al.
Annals of Neurology|September 1, 1985
Clinical history, brain metabolism, and neuropsychological function in Alzheimer's diseaseN R Cutler, J V Haxby, R Duara, et al.
Neurobiology of Aging|January 1, 1987
CSF and serum concentrations of albumin and IgG in Alzheimer's diseaseA D Kay, C May, N M Papadopoulos, et al.
Science (New York, N.Y.)|August 19, 1983
Down's syndrome in adults: brain metabolismM Schwartz, R Duara, J Haxby, et al.
Neurology|April 1, 1988
Cerebrospinal fluid monoamine markers are decreased in dementia of the Alzheimer type with extrapyramidal featuresJ A Kaye, C May, E Daly, et al.
Pageof 4